Rewind Therapeutics

Belgium
Antwerpen, Flanders, Belgium

Company profile

Rewind Therapeutics company profile

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medical practitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0+
Founded
2017-01-01, Year

Headquarters

Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$18.3M
Last funding
Series A / 2023-01-25
Last equity funding
Series A
Investors
7
Lead investors
5
Articles
11

Founders and investors

Lead investors

Agentschap Innoveren & OndernemenBoehringer Ingelheim Venture FundM VenturesPMVSunstone Life Science Ventures

Investors

Boehringer Ingelheim Venture FundCentre for Drug Design & Discovery (CD3)Gemma Frisius FundM VenturesSunstone Life Science Ventures